Clopidogrel is used to reduce atherosclerotic events (MI, stroke and vascular death) in patients w / atherosclerosis documented by recent stroke, MI or established peripheral arterial disease. Low dosage aspirin appear to inhibit clot formation by blocking the synthesis of prostaglandin, which in turn prevents formation of the plateletaggregating substance thromboxane a2.
Clopidogrel is used to reduce atherosclerotic events (MI, stroke and vascular death) in patients w / atherosclerosis documented by recent stroke, MI or established peripheral arterial disease. Low dosage aspirin appear to inhibit clot formation by blocking the synthesis of prostaglandin, which in turn prevents formation of the plateletaggregating substance thromboxane a2.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Clopidogrel is used to reduce atherosclerotic events (MI, stroke and vascular death) in patients w / atherosclerosis documented by recent stroke, MI or established peripheral arterial disease. Low dosage aspirin appear to inhibit clot formation by blocking the synthesis of prostaglandin, which in turn prevents formation of the plateletaggregating substance thromboxane a2.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Drug Classification: Anticoagulant, antithrombotics & fibrinolytics Indication: for the reduction of atherosclerotic events (MI, stroke & vascular death) in patients w/ atherosclerosis documented by recent stroke, MI or established peripheral arterial disease. For the treatment of patients suffering from non- ST segment elevation acute coronary syndrome (unstable angina or non-Q wave MI) in combination w/ ASA. Mechanism of Action: low dosage aspirin appear to inhibit clot formation by blocking the synthesis of prostaglandin, which in turn prevents formation of the platelet- aggregating substance thromboxane A2. Clopidogrel Dosage: 75 mg daily Contraindication: Severe liver impairment. Peptic ulcer and intracranial hemorrhage. Lactation. Special Precaution: Patients who may be at risk of increased bleeding from trauma, surgery or other pathological conditions. Patients w/ moderate hepatic disease who may have bleeding diatheses. Pregnancy. Adverse Reaction: CNS: depression, dizziness, fatigue, headache EENT: epistaxis RESP: cough, dyspnea CV: Chest pain, edema, hypertension GI: GI bleeding, abdominal pain, diarrhea, dyspepsia, gastritis DERM: pruritus, purpura, rash HEMAT: bleeding, neutropenia, thrombotic thrombocytopenic purpura METAB: hypercholesterolemia MS: arthralgia, back pain MISC: fever, hypersensitivity reactions Form: Film- coated tablet- 75mg Pregnancy Risk Category: B Nursing Responsibilities: Assess patient for symptoms of stroke, peripheral vascular disease, or MI periodically during therapy. Monitor patient for signs of thrombotic thrombocytic purpura (thrombocytopenia, microangiopathic hemolytic anemia, neurologic findings, renal dysfunction, fever). Monitor bleeding time during therapy. Monitor CBC with differential and platelet count periodically during therapy.